Testagen

Testagen is the tetrapeptide Lys-Glu-Asp-Gly, written H-Lys-Glu-Asp-Gly-OH and abbreviated KEDG. It is sold with reference to testicular tissue and testosterone.

Nothing has been demonstrated in reproductive tissue; what has been shown is chemistry. In the 2011 work KEDG was one of four short peptides — with Epitalon, Pinealon and Bronchogen — observed reaching the nucleolus of HeLa cells, with binding preferences reported for CNG-type sequences and sensitivity to cytosine methylation ( Fedoreyeva et al., Biochemistry (Mosc) 2011). The leap from that to testicular gene regulation is made by the theory, not by an experiment.

There is no indication anywhere. Hypogonadism and infertility are diagnosed on measured hormone levels and treated with therapies that carry labels and monitoring requirements; KEDG has never been evaluated against those endpoints in any species.

One point is specific to this compound. KEDG is marketed with testosterone language, and anabolic androgenic steroids sit in category S1 as prohibited at all times — so a vial with unverified contents and testosterone marketing is a poor risk for anyone in a testing pool. S0 covers unapproved substances in any case.

There is no safety literature to summarise: no animal toxicology, no human exposure report, no case series. When the published record consists of a cell-imaging paper and a metallurgy paper, claims that a compound is "generally well tolerated" have no source behind them.

No pharmacokinetic parameter has been measured for KEDG in any organism. Without a single exposure measurement, dose discussion would be fabrication.

Sold as a lyophilised powder, often in "male vitality" bundles with gonadorelin, hCG or enclomiphene — compounds that do have measurable endocrine effects and, in some cases, regulatory approval. The packaging lends KEDG a pharmacological company it has not earned.

The 2025 paper illustrates the situation better than any caveat could. Published in Molecules, it is an electrochemistry and computational study reporting that KEDG adsorbs onto copper and inhibits corrosion in saline with roughly 86% efficiency ( Dobriţescu et al., Molecules 2025). It is competent science with nothing to say about human physiology. When the newest and most rigorous work naming a compound is materials science, the biological claim on its label is unsupported rather than merely under-supported.

For deeper dives on this peptide, see:

• Testagen benefits and areas of interest
• Testagen side effects and safety context
• Testagen dosing concepts (educational)
• Testagen research and evidence overview

Does Testagen raise testosterone? No study has measured testosterone after giving KEDG to anything. The claim exists in product copy and nowhere in the scientific record.

Why does it have so much less research than Epitalon? Epitalon attracted an outside interest the rest of the range never did — telomeres and lifespan — and accumulated roughly 140 indexed records. Testagen was assigned an organ, given a name and left alone; it has two.

How does it differ from Epitalon chemically? Both are tetrapeptides ending in glycine: Epitalon is Ala-Glu-Asp-Gly, Testagen swaps the alanine for lysine. One residue separates the family's best-studied member from its least-studied one — a poor advertisement for the idea that each sequence targets its own organ.

Is it legal to buy? Legality varies by country, but it holds no medicine authorisation from the FDA, EMA or MHRA, and research-chemical material is not made to pharmaceutical standards.